Novartis to Sell 14 Long-Listed Brands to Sun Pharma in Japan, Likely to Stop Aredia Sales

India’s Sun Pharmaceutical Industries has announced a US$293 million cash deal to buy Novartis’s 14 established brands in Japan, marking inroads into the Japanese ethical drug market, but the two companies’ local subsidiaries have remained mum on its details. Sun...read more